ART26.12

Pharmaceutical compound From Wikipedia, the free encyclopedia

ART26.12 is an experimental drug that acts as a selective inhibitor of the enzyme FABP5, which usually breaks down endocannabinoids such as anandamide. ART26.12 thereby boosts endocannabinoid levels and has analgesic effects, showing efficacy against atypical pain syndromes such as hyperalgesia and allodynia. It is being researched as a potential treatment for neuropathy which can occur as a side effect of some kinds of chemotherapy, as well as showing activity against psoriasis.[1][2][3][4]

CAS Number
FormulaC29H28O6
Molar mass472.537 g·mol−1
Quick facts Identifiers, CAS Number ...
ART26.12
Identifiers
  • (2R,4R)-3-(2,3-dihydro-1H-inden-2-yloxycarbonyl)-2,4-bis(2-methoxyphenyl)cyclobutane-1-carboxylic acid
CAS Number
PubChem CID
Chemical and physical data
FormulaC29H28O6
Molar mass472.537 g·mol−1
3D model (JSmol)
  • COC1=CC=CC=C1[C@@H]2C([C@H](C2C(=O)OC3CC4=CC=CC=C4C3)C5=CC=CC=C5OC)C(=O)O
  • InChI=1S/C29H28O6/c1-33-22-13-7-5-11-20(22)24-26(28(30)31)25(21-12-6-8-14-23(21)34-2)27(24)29(32)35-19-15-17-9-3-4-10-18(17)16-19/h3-14,19,24-27H,15-16H2,1-2H3,(H,30,31)/t24-,25-,26?,27?/m1/s1
  • Key:HFKXLDACQCGGEI-BINWOUKTSA-N
Close

References

Related Articles

Wikiwand AI